Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (257)	9/11/2011 3:18:19 PM
From: IRWIN JAMES FRANKEL	4 Recommendations Read Replies (1) \| Respond to of 400

Hi Bulba, Perry's treason charge against Bernanke and the Ponzi allegation on SS* is TOO much for this conservative. When politicians "lead" by selecting a set of views that will poll well (with their perceived constituency), they are not leaders - just a modern technology-enabled follower. It is no wonder with such sycophant "leadership" that we are polarized as a nation. In the process, truth is obscured as personal delusions are passed off as the "truth". Kind regards, Jim * I understand that there are similarities that can be drawn since the group receiving benefits are paid by another group that may not receive a commensurate benefit. But describing SS as a Ponzi scheme is ignorant and destructive.

To: BulbaMan who wrote (257)	9/16/2011 5:19:06 PM
From: BulbaMan	Respond to of 400

9/16/11 Contest Update We’re all “rogue traders” now! No doubt that’s what they’ll be calling investors after the next stock market crash. Here’s Matt Taibbi’s take on the latest “rogue trader” scandal: rollingstone.com No crash this week, however, as hopeful investors did more buying than selling. At Friday’s close, the NBI was up 4.80% YTD (vs. up .59% YTD a week ago) and the Contest median was down -1.66% YTD (vs. down -5.54% YTD a week ago). The Nasdaq Composite Index was down -1.15% YTD (vs. down -6.97% YTD a week ago). GENE’s portfolio (up 52.29 % YTD) remained our leader, while JIBAC’s portfolio (up 42.88%YTD) held on to second place and ROCKY’s portfolio (up 39.27% YTD) regained third place. At Friday's close, 18 of the 38 Contest portfolios were in the black, while 13 of the 38 were beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables). Portfolio adjustments: The ICGN cash from Pfizer’s $6 tender appeared in in my real-life account on Wednesday, 9/14. So, as indicated in last week’s update, I used 9/14 closing prices to reallocate the Pfizer proceeds for those Contest portfolios holding ICGN (BIOFISH, GENE, JIBAC, RKRW). Be kind to yourself this weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 9/16/11 Rank Name Profit/Loss 1 GENE 52,294 2 JIBAC 42,882 3 ROCKY 39,269 4 MCBIO 38,134 5 FIB 27,787 6 GHMM 20,390 7 RRGE 18,186 8 IJF 14,602 9 JULIUS 13,274 10 RKRW 10,281 Week's Top 5 Gainers Symbol 9/9 9/16 % change DRRX 1.43 1.87 30.77% ARNA 1.25 1.56 24.80% BMTI 3.30 4.04 22.42% OREX 1.28 1.55 21.09% TLON.OB 0.91 1.09 19.78% Week's Top 5 Losers Symbol 9/9 9/16 % change CBPO 8.50 7.42 -12.71% MSHL 1.51 1.33 -11.92% ROSG 1.28 1.14 -10.94% KOOL 1.63 1.48 -9.20% NRGX.OB 0.55 0.50 -9.09%